Unable to display view head.php file not found.
 
 

James A. Reiffel, MD - Novel Oral Anticoagulants - Figure 43

Rivaroxaban: Efficacy and Safety

This Figure summarizes the principal efficacy and safety endpoint results with rivaroxaban for prophylactic anticoagulation in patients with nonvalvular AFib.

 Reiffel JA. Am J Med 2013; 126: 00-00.

Complete references for all slides

References

[97] Patel MR, Mahaffey KW, Garg J, et al; the ROCKET AF Steering Committee, for the ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883-891.

Unable to display view foot.php file not found.